From: Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
Gene | Gene-ID | Cytoband | Amplicon position (NCBI Build 35.1 [hg17]) | Amplicon position (hg18) |
---|---|---|---|---|
S100A8 | 6279 | 1q21 | chr1:150,175,956–150,176,071 | chr1:151,629,507–151,629,622 |
FN1 | 2335 | 2q34 | chr2:216,112,380–216,112,466 | chr2:215,995,119–215,995,205 |
RAF1 | 5894 | 3p25 | chr3:12,635,039–12,635,148 | Identical |
DAB2 | 1601 | 5p13 | chr5:39,418,493–39,418,602 | identical |
CSPG2 | 1462 | 5q14.3 | chr5:82,821,732–82,821,832 | identical |
E2F3 | 1871 | 6p22 | chr6:20,598,410–20,598,516 | identical |
SFRP1 | 6422 | 8p12-p11.1 | chr8:41,285,606–41,285,686 | identical |
TUSC3 | 7991 | 8p22 | chr8:15,524,970–15,525,081 | identical |
EDD1 | 51366 | 8q22 | chr8:103,366,989–103,367,080 | identical |
MYC | 4609 | 8q24.12-q24.13 | chr8:128,822,158–128,822,287 | identical |
CDKN2A | 1029 | 9p21 | chr9:21,957,845–21,957,973 | identical |
KLF4 | 9314 | 9q31 | chr9:107,331,117–107,331,240 | chr9:109,291,383–109,291,506 |
MDM2 | 4193 | 12q14.3-q15 | chr12:67,519,751–67,519,858 | Identical |
RB1 | 5925 | 13q14.2 | chr13:47,853,426–47,853,564 | Identical |
TP53 | 7157 | 17p13.1 | chr17:7,520,091–7,520,236 | Identical |